Abstract
This study aimed to analyze patents published at the World Intellectual Property Organization (WIPO) database related to biotechnological applications of β-galactosidase. China stood out as the holder of the majority of patent deposits. 53% of the documents came from universities; 43% of the patents were classified as technological processes, 36% as products, 19% enzyme enhancement, and 2% as analytical determination. Most of the patents were related to improved production of β-galactosidase. Lactose-free dairy products have increased the number of β-galactosidase patents over the last five years, especially for the production of GOS and dairy-free final products.

This publication has 16 references indexed in Scilit: